T
Tandem Diabetes Care Inc (TNDM)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$18.48
-1.59 (-7.92%)
Market Cap: $1.40B
Last updated: Nov 17, 2026 at 11:06 AM ET
Tandem Diabetes Care Inc (TNDM) Valuation Multiples
Tandem Diabetes Care (TNDM) trades at 1.2x sales and 9.5x book value. Its P/S of 1.2x is below its 5-year median of 2.4x. Its forward P/E is 222.2x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 222.2x |
| Price to sales | 1.2x |
| Price to book | 9.5x |
| PEG | N/A |
| FCF yield | -2.8% |
Historical Medians
Against its 10-year medians, its P/S is 62.5% below 3.2x and its P/B is 18.1% below 11.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.2x | 2.4x | 3.2x |
| P/B | 9.5x | 8.5x | 11.6x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 0.1x in 2017 to 13.6x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $21.98 | N/A | 1.5x | 9.6x |
| 2024 | $36.02 | N/A | 2.5x | 9.1x |
| 2023 | $29.58 | N/A | 2.6x | 6.2x |
| 2022 | $44.95 | N/A | 3.6x | 6.6x |
| 2021 | $150.52 | 654.4x | 13.6x | 22.9x |
| 2020 | $95.68 | N/A | 11.9x | 17.2x |
| 2019 | $59.61 | N/A | 9.8x | 19.2x |
| 2018 | $37.97 | N/A | 8.9x | 17.6x |
| 2017 | $2.36 | N/A | 0.1x | N/A |
| 2016 | $21.50 | N/A | 0.8x | N/A |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About TNDM
What is TNDM's forward P/E ratio?
Tandem Diabetes Care has a forward P/E ratio of 222.2x.
Is TNDM stock overvalued?
GNG's valuation label for TNDM is Undervalued.
What is TNDM's price to sales ratio?
Tandem Diabetes Care has a price to sales ratio of 1.2x.
TNDM pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors